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Tourette’s syndrome (TS) is a neurodevelopmental disorder characterized by fluctuating
motor and vocal tics, usually preceded by sensory premonitions, called premonitory
urges. Besides tics, the vast majority—up to 90%—of TS patients suffer from
psychiatric comorbidities, mainly attention deficit/hyperactivity disorder (ADHD) and
obsessive-compulsive disorder (OCD). The etiology of TS remains elusive. Genetics is
believed to play an important role, but it is clear that other factors contribute to TS,
possibly altering brain functioning and architecture during a sensitive phase of neural
development. Clinical brain imaging and genetic studies have contributed to elucidate
TS pathophysiology and disease mechanisms; however, TS disease etiology still is
poorly understood. Findings from genetic studies led to the development of genetic
animal models, but they poorly reflect the pathophysiology of TS. Addressing the role
of neurotransmission, brain regions, and brain circuits in TS disease pathomechanisms
is another focus area for preclinical TS model development. We are now in an interesting
moment in time when numerous innovative animal models are continuously brought to
the attention of the public. Due to the diverse and largely unknown etiology of TS, there
is no single preclinical model featuring all different aspects of TS symptomatology. TS
has been dissected into its key symptomst hat have been investigated separately, in line
with the Research Domain Criteria concept. The different rationales used to develop
the respective animal models are critically reviewed, to discuss the potential of the
contribution of animal models to elucidate TS disease mechanisms.
Keywords: tics, repetitive behavior, genetics, environment, PPI, TS comorbidities
INTRODUCTION
TS Definition, Epidemiology, Symptoms, and Natural Course
Tourette’s Syndrome (TS) was named after Georges Gilles de la Tourette (1857–1904) who first
described it as a “tic syndrome” in 1885 and whose observations are still considered mostly valid
today. Tics are involuntary movements or vocalizations that can involve different parts of the body
changing in frequency, intensity and duration. A diagnose of TS requires the presence of both
Abbreviations: ADHD, Attention Deficit/Hyperactivity Disorder; CSTC, Cortico-striato-thalamo-cortical circuit; DA,
Dopamine; DOI, 2,5-Dymethoxy-4-iodoamphetamine; DR, Dopaminergic Receptor; DSM-5, Diagnostic and Statistical
Manual of Mental Disorders, Fifth Edition; GABA, Gamma-Aminobutyric acid; GPe, Globus pallidus externus; HDC,
Histidine decarboxylase; KO, Knock-out; NTs, Neurotransmitters; OCD, Obsessive-Compulsive Disorder; PPI, Pre-Pulse
Inhibition; PU, Premonitory Urge; TS, Tourette’s Syndrome.
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multiple motor and one or more vocal tics with an onset before
age 18 years and a persistence for at least 1 year (DSM-5).
But TS is not only about tics: up to 90% of all TS patients
experience psychiatric comorbidities, mainly Attention
Deficit/Hyperactivity Disorder (ADHD) and obsessive
compulsive disorder (OCD), but also depression, anxiety
disorders, conduct disorders, personality disorders, and self-
injurious behaviors (Khalifa and Knorring, 2007; Cavanna et al.,
2009; Pallanti et al., 2011).
TS has long been considered to be rare, as it was reported to
affect only 1 in 2000 (Bruun, 1984). Nowadays the prevalence
of TS in the general population has been re-evaluated, and is
estimated to be 0.4–1% (Robertson et al., 2009), but could be
even higher since, especially in childhood, tics are often so mild
that are hardly perceived and easily overlooked. In many cases
only an expert eye is able to identify tics in patients presented
to the clinician as a consequence of behavioral problems or
ADHD.
Role of CSTC Circuitry in TS Pathophysiology
The exact neurobiological background of TS remains still unclear,
but a central role of the cortico-striato-thalamo-cortical (CSTC)
circuit appears uncontroversial, as numerous anatomical and
functional imaging studies were able to detect morphological
and functional alterations in CSTC components of TS patients
compared to controls (Singer et al., 1993; Peterson et al., 2003;
Sowell et al., 2008).
The pre-motor and motor cortices, the striatum, composed
of caudate and putamen, the globus pallidus internus (GPi) and
externus (GPe), the subthalamic nucleus (STN), the thalamus,
and the substantia nigra (SN) are connected in the CSTC
circuit. Under physiological circumstances, an activation of this
circuit physiologically results in voluntary movements, while
involuntary movements are repressed.
Movements occur as the motor cortex is activated by the
thalamus, which is controlled by the STN-GPe-GPi microcircuit.
When the pre-motor cortex activates the putamen, the inhibitory
striatal projection neurons release the thalamus from inhibition
held by the STN-GPe-GPi, and eventually the motor cortex
can be activated, leading to movement (Obeso and Lanciego,
2011).
Tics are supposed to be caused by a deregulated activity of the
basal ganglia, which consequentially leads to disinhibition of the
thalamus and a hyperexcitability of the motor cortex (Albin and
Mink, 2006; Wang et al., 2011).
When the beneficial effect of dopaminergic modulators such
as haloperidol and pimozide on tic management was observed,
a dysfunction in the dopaminergic system was seen as the main
responsible of TS neuropathology (for review see Buse et al.,
2013). Nowadays the use of haloperidol and pimozide has been
gradually left aside in favor of the better tolerable atypical
antipsychotics and atypical neuroleptics, such as aripiprazole or
risperidone, acting on dopamine and serotonin. In general, there
is growing evidence indicating that TS is not a pure DA-related
disorder, and the interplay of other neurotransmitters is strongly
supported to contribute or cause the disease (for review see
Udvardi et al., 2013; Figure 1).
Importance of a TS Animal Model
In vivo animal models are important tools to challenge and
validate pathophysiological hypotheses and test new therapeutic
options. An animal model is constructed to fulfill one or
more of the following parameters: face validity (ability to show
similar symptoms to the patients’ ones), construct validity (model
developed according to a rationale matching the pathological
hypothesis), and predictive validity (model responds to a
treatment similarly to patients). The ideal model is able to show
all these three features, but in most cases the main focus remains
on one of the three aspects. The use of animal models could help
the major means of investigations of TS thanks to their ability
to verify pathophysiological hypotheses and test pharmacological
compounds.
METHODS
This article is a review about the “now-in-use” preclinical models
of TS, extracted from the literature of the last decade. As a
perfect model for TS has not yet been produced, we aim at
showing the different successful methods used by researchers to
independently model all major aspects involved in TS pathology,
that we separately describe and analyze. Strengths and limitations
of animal models are explained with a focus on recent research
findings. The aim is to provide up-to-date information on TS
animal models for students, researchers, and clinicians, and hints
to be used by preclinical experimenter in developing new TS
animal models.
Electronic literature search via MEDLINE/PubMed has been
conducted for articles that had been published in English since
year 2000. Combinations of keywords were used to identify
relevant articles, including: “Tourette Syndrome,” “TS animal
model,” “TS in vivo,” “motor tic,” “stereotype,” “premonitory
urge,” “PPI,” “genetic TS,” “environment TS,” “immune TS,”
“ADHD,” “TS neurobiology,” “OCD.” Systematic and narrative
reviews, as well as original research articles were included. The
last search was conducted on November 2015. The literature
search was also supplemented with key publications and book
chapters known to the authors.
TS PHENOMENOLOGY
Genetics
TS has a strong genetic basis. Family studies in children with TS
reveal that 8–57% of their parents had a history of tics, and first-
degree relatives had a significant increased risk of developing the
disorder (Pauls et al., 1991). Twin studies also report a 53–56%
concordance rate for TS in monozygotic twins, compared with
only 8% in dizygotic twins (Price et al., 1985; Hyde et al., 1992).
The initial idea of TS being a monogenic Mendelian disorder
has been quickly revised and TS is now considered a complex
disorder with many open questions regarding its overall genomic
architecture. The identification of TS-related genes through
linkage and association studies is hindered by the unclear mode
of inheritance, the genetic heterogeneity of the disease and its
apparently incomplete penetrance (Pauls, 2003).
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FIGURE 1 | Structure and compartments of CSTC circuit. (A) Representation of a left side of human brain coronal section depicting the anatomical localization of
the basal ganglia components and the cerebral cortex. (B) Schematic illustration of the CSTC internal network within the circuit depicting the glutamatergic (red
arrow), GABAergic (blue arrow) and the dopaminergic connection (yellow arrow). Abbreviations: GPe, Globus Pallidus pars externa; GPi, Globus Pallidus pars interna;
STN, Nucleus Subtalamicus; SNc, Substantia Nigra pars compacta; SNr, Substantia Nigra pars reticulata.
Specific genetic abnormalities have so far been identified in
less than 1% of patients, including polymorphisms and copy
number variation. Many of these findings also parallel those
of other common neuropsychiatric and neurodevelopmental
disorders, unveiling previously unknown disease mechanisms,
but their specific role for TS has rarely been elucidated
(Sundaram et al., 2010; Crane et al., 2011; Scharf et al., 2013;
Bertelsen et al., 2015).
Modeling TS Genetics
Animal genetic manipulation has widely been a key starting point
to model numerous diseases.
Sequence variants in Slirtk 1 were found in TS patients and
associated to loss of function in supporting dendritic growth
during development of numerous components of CSTC circuit
(Abelson et al., 2005). Slitrk1 KO mice exhibit elevated anxiety-
and depression–like behaviors, symptoms which have also been
associated withTS-spectrum disorder (Katayama et al., 2010).
The discovery of a mutation in the histidine decarboxylase
(Hdc) gene in a unique family withmarked history of tic disorders
lead to the investigation of the disruption of histaminergic
pathway in animal models. The core phenomenology of TS, tic-
like behaviors, are not observed in Hdc KO mice at baseline, but
stereotypies as repetitive sniffing and orofacial movements can be
elicited by activating the dopamine system with D-amphetamine
and are ameliorated after intracerebral administration of
dopamine antagonist haloperidol. Fear conditioning significantly
increased grooming in these animals (Castellan Baldan et al.,
2014)1.
1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894588/.
Furthermore, significant pre-pulse inhibition (PPI) deficits
and striatal dopamine dysregulation have also been observed
in Hdc KO mice, aligning human findings and supporting the
interplay between histamine and dopamine, the major known
player in TS (Rapanelli et al., 2014; Xu et al., 2015a).
Another recent genetic TS animal model has been developed
based onthe observation that cholinergic interneurons are
reduced by 50% in TS patient’s striatum (Kataoka et al., 2010;
Lennington et al., 2014): region-specific knockout of choline
acetyltransferase in the dorsolateral striatum led to stress-
induced increase in grooming. D-amphetamine administration
did not increase the amount of grooming activity, but the
animals performed more repetitive stereotyped actions (Xu et al.,
2015b)2.
A main regulator of striatal activity is dopaminergic system
whose alterations have been correlated with TS severity and
the development of comorbidities. Genetic manipulation has
been used as tool to address dopaminergic contribution to
the pathology, even though genetic evidence for dopaminergic
dysfunction has not been found in TS patients yet. Dopamine
transporter (DAT) KOmice (Berridge et al., 2005) and dopamine
receptor 3 (DR3) KO mice (Garner and Mason, 2002) are
characterized by a hyperdopaminergic condition and show
stereotypies, consolidating their role in repetitive behavior.
Furthermore, DAT KO mice show a more complex and rigid
sequence of actions during grooming, which is in between tics
of TS and compulsions of OCD.
The lack of a clear, spontaneous “ticcing” phenotype in
these genetic animal models raises the question of further
2http://www.pnas.org/content/suppl/2015/01/02/1419533112.DCSupplemental.
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neurotransmitters, synaptic, or developmental mechanisms that
need to be evaluated (Table 1).
Tics
A tic is a sudden, rapid, recurrent, non-rhythmic, jerk-like
movement, or vocalization that can vary in frequency, intensity,
duration and anatomical localization. Tics are classified as simple
or complex according to the number of groups of muscles
involved, and as motor or vocal tics.
Simple tics usually last fewmilliseconds engage one or a group
of muscles like those involved in eye blinking (simple motor
tic) or throat clearing (simple vocal tics). Complex tics last few
seconds and can be defined as a combination of simple tics.
They can appear purposeful like performing obscene gesture
(copropraxia) or uttering racial slurs (coprolalia) or may consist
in the imitation of someone elses′ actions (echopraxia) or words
(echolalia).
Three different tic disorders are included in the DSM-5:
provisional tic disorder, persistent motor, or vocal tic disorder
and TS. The difference between these disorders relies on the
type of tics observed (motor, vocal, or both), and how long the
symptoms have lasted. The presence of both motor and vocal
tics for a period longer then 1 year since first onset (before 18
years of age) and their “waxing and waning” course differentiate
TS. Indeed, they may show a pattern in which old and new tics
overcome and fluctuate in frequency and intensity over time.
Other hyperkinetic movements can occur in TS patients and
can be easily misdiagnosed and lead to a wrong treatment
approach (Kompoliti and Goetz, 1998). This is the case of
stereotypies that are fixed, prolonged and rhythmic repetitive
behaviors and present an average age of onset of 3 years
(DSM-5). Unlike stereotypies, tics are tipically preceded by an
uncomfortable phenomenon called “premonitory urge” (PU) and
can be voluntarily suppressed by most patients for a short period
of time.
In general, tics are intensified by stress, anxiety, excitement,
anger, fatigue, or infections (Lombroso et al., 1991; Nelson, 1993;
Lin et al., 2007) while their reduction is reported in patients
performing focused and effortful activities (Conelea and Woods,
2008).
Modeling Tics
The clear terminology available for clinicians to identify motor
disorders is not easily applicable by in vivo experimenters, as any
parallelism between human and animal condition must be taken
carefully.
Literature testifies the lack homogeneity employed to name
motor phenotypes in animal models of TS, ranging from
“tic,” to “tic-like movement,” or “repetitive movements” and
“stereotypies.”
Several animal models of tics have been obtained through
systemic or focal administration of active substances, which give
a transient but easy to replicate phenotype. Importantly, different
compounds with diverse effects were proven to be effective in the
induction of tic-like behavior.
The intracerebral infusion of GABAergic antagonists is
becoming a more and more appealing strategy of tic-like
movement induction and has led to the formulation of the
TABLE 1 | Genetic animal models of TS.
Transgenic Model Gene target Association to TS Phenotype References
Slitrk1 KO mouse SLIT and NTRK-like
protein1
Slitrk1 mutated variants Anxiety-like and depression-like behavioral abnormalities
attenuated by clonidine (α2 adrenergic agonist) treatment





Increased grooming after D- amphetamine (5-HTR
agonist) administration or stress. Stereotypies in HDC
KO mice are mitigated by haloperidol (DA agonist)
pretreatment







No tic-like stereotypies and PPI deficit at baseline;
increased and fragmented grooming after acoustic
startle stimuli; increased stereotypies after amphetamine
(5-HTR agonist) administration
Xu et al., 2015b
DAT-KO mouse Dopamine transporter – Hyperdopaminergia in striatum and supestereotypies. Berridge et al., 2005
DA/5-HT imbalance in basal ganglia Pogorelov et al., 2005
PPI deficits and perseverative motor patterns Ralph et al., 2001
DRD3-KO mouse Dopamine receptor D3 – Increase in spontaneous stereotypies Garner and Mason,
2002
Hyperlocomotor activity after amphetamine (5-HTR
agonist) treatment
McNamara et al., 2006
DRD3-KO rat – Hyperactivity and rotational behaviors
List of TS animal models obtained through genetic manipulation. Note that not all human genetic mutations known to have a role in TS have been used to create a valid TS preclinical
model. On the other hand, several transgenic animal models have shown a TS-related phenotype but no correlation with a known TS mutation has been found so far. Abbreviations:
5HT2c-KO, Serotonin receptor knock out; CNTNAP2, Contactin-associated protein-like2; COL27A1, Type XXVII collagen alpha chain gene; CRL, controls; DAT-KO, Dopamine transporter
knock out; DAT-KD, Dopamine transporter knock down; DRD1-KD, Dopamine receptor D1 knock down; DRD3-KO, Dopamine receptor D3 knock out; GABRB3, GABA A-receptor
beta-3; HDC, Histidine decarboxylase; IMMP2L, Inner mitochondrial membrane peptidase; NLGN4X, Neuroligin-4 protein; POLR3B, polymerase (RNA) III (DNA directed) polypeptide
B; PPI, Pre-pulse Inhibition; SLITRK1, SLIT and NTRK-like protein1; 5-HTR, serotonin receptor.
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hypothesis that disequilibrium between cortical glutamatergic
output and striatal GABAergic metabolism plays an important
role in tic induction. The GPe was one of the first basal ganglia
components to be investigated with this approach (Grabli et al.,
2004), but is now the functional disruption of the striatum to be
the major target of investigation.
Striatal injections of the GABAergic antagonist bicuculline
in primates cause simple tic-like movements, hyperactivity
and stereotyped behaviors (McCairn et al., 2009). These
three phenotypes are independent processes and appear to
be associated with different brain regions: the sensorimotor
network, the prefrontal cortex and associative territories and
the orbitofrontal cortex and limbic part of the basal ganglia
respectively (Worbe et al., 2013). Electrophysiological data also
suggest a role for the cerebellum in tic expression in this model
(McCairn et al., 2013). The application of the same approach in
adult rats results in an acute tic session that varies in intensity
and body parts involved and is characterized by additional
hyperactivity (Bronfeld et al., 2013)3. In mice, tics were also
evoked by striatal picrotoxin injections, while cortical injections
induce seizures (Pogorelov et al., 2015)4.
Systemic administration of hallucinogens acting on serotonin
receptors (Tizabi et al., 2001; Fantegrossi et al., 2005, 2006;
Halberstadt and Geyer, 2014; Ceci et al., 2015) induce head-
twitches responses, while the use of monoamines modulators,
induces stereotypies (Lv et al., 2009; Taylor et al., 2010).
Stereotypic behaviors were also observed after administration of
3,3′-iminodipropionitrile (IDPN) (Wang et al., 2013) and Catha
edulis extract (Oyungu et al., 2007).
The D1CT-7 transgenic mouse, originally proposed for OCD,
shows head twitching and abnormal movements of limbs and
trunk with juvenile onset and sexual dimorphism (Nordstrom
and Burton, 2002). These animals display PPI deficits and tic-
like manifestations that are increased in presence of spatial
confinement-induced. This model appears to show higher
hyperactive stress reduced by antipsychotics and clonidine
(Nordstrom et al., 2015), making it the first model to show face
validity for tics and feature also common TS-related phenotypes
(Table 2).
Premonitory Urge
Since pediatric age, TS patients become aware of an
uncomfortable sensation that precedes tics known as
premonitory urge (PU) that, for about 57% of cases, is more
bothersome then tics themselves (Cohen and Leckman, 1992;
Reese et al., 2014).
From a therapeutic point of view, the understanding of PU
might help tic management since it could enhance the patient’s
own ability to suppress it (Leckman et al., 1993; Frank and
Cavanna, 2013).
In adult TS patients the neurophysiological system of urge
and tic generation appears to be distinct from the one implied
in tic control (Ganos et al., 2012): the urge would include




(anterior cingulate cortex and supplementary motor area), while
tic generation is known to take place in prefrontal structures
involved in the primary inhibition of the motor control, as
confirmed by neuroimaging studies (Peterson et al., 1998).
The genesis of PU is still unknown but some evidence led
to the hypothesis that this feeling might reflect abnormalities
of sensorimotor gating, i.e., the neurological process able to
filter out redundant or unnecessary environmental stimuli that
constantly reach our brain (Braff et al., 2001; Biermann-Ruben
et al., 2012).
Modeling TS Sensorimotor Gating Deficit
Tics are, to a certain extent, an easy-to-detect phenomenon; PU
is more complicated to be translated into a preclinical model
but can be investigated through the study of sensorimotor gating
deficit.
To assess sensorimotor gating functions, the pre-pulse
inhibition (PPI) of the startle response is used in both humans
and laboratory animals. PPI is a behavioral phenomenon in
which a weak pre-stimulus (i.e., prepulse) diminishes the
reaction to a subsequent stronger stimulus (i.e., pulse) that
could otherwise trigger a strong startle response. In presence
of acoustic, visual or tactile stimuli, TS patients show PPI
deficits manifesting the inability to filter unnecessary information
(Castellanos et al., 1996; Zebardast et al., 2013).
Due to its conformity to the validity criteria, this animal
model of sensorimotor gating deficits has now reasonably
been extended from the single research of schizophrenia (Wan
and Swerdlow, 1996) to the study of TS and its comorbidities
(Swerdlow and Sutherland, 2005). In rodents, PPI appears to
be regulated by the nucleus accumbens and its dopaminergic
activation. Similar to tics, PPI abnormalities develop in rats
treated with dopaminergic agonists (Alsene et al., 2010; Mosher
et al., 2015), hallucinogens (Swerdlow et al., 2003; Chen
et al., 2012) and glutamate antagonists (Swerdlow et al., 2007;
Pietraszek et al., 2009). PPI deficit could also be detected in
spontaneous hypertensive rats (SHR), the model of choice for
ADHD (Van Den Buuse, 2004; Table 3).
Environmental Risk Factors
Similar to other developmental neuropsychiatric disorders, TS
perfectly fits in a so-called “multistrike model” of etiology. In
this model the first hit is represented by the genetic vulnerability
to the disease that is likely to be translated in structural
and functional neurological changes. If these changes disturb
regions with physiological self-regulatory functions -second hit-
tic expression is evoked. In addition, various environmental
factors (neuroendocrine, infectious, autoimmune, toxic, and
psychosocial influences), representing a third strike, further
increase the risk of tic expression (Spessot et al., 2004).
Numerous studies have investigated environmental factors
that might contribute to the onset and severity of TS and
associated comorbidities. Chao et al. (2014) systematically
reviewed studies investigating the contribution of pre- and
perinatal adverse events on onset and severity of TS and its
comorbidities, if present.
Maternal smoking appears to be consistently implicated to TS
pathology (Mathews et al., 2006; Motlagh et al., 2010).
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Infections, and particularly Pediatric Autoimmune
Neuropsychiatric Disorders Associated with Streptococcal
Infections (PANDAS) were associated to worsening or causing
TS (Kurlan, 2004; Kirkman et al., 2008; Singer et al., 2012; Swedo
et al., 2012), however, a causal relationship between streptococcal
infections and TS is still under investigation (Hoekstra and
Minderaa, 2005; Krause et al., 2010).
Finally, only a few clinical studies were conducted
investigating the extent to which stressors affect TS patients’ life
(Silva et al., 1995) but TS patients report a strong link between
stress and tics exacerbation. The hypothalamic-pituitary-adrenal
axis is supported to have an enhanced responsivity in children
with TS (Corbett et al., 2008) and tic severity seems to correlate
to cortisol levels (Conelea and Woods, 2008).
Modeling TS Environmental Risk Factors
Several immune-mediated models have been developed
according to different strategies.
Passive exposure to immunomediators (Ponzio et al., 2007;
Smith et al., 2007; Depino et al., 2011; Patel et al., 2012; Zalcman
et al., 2012) or to immunogenic microbial components (Hoffman
et al., 2004; De Miranda et al., 2010; Yaddanapudi et al., 2010;
Brimberg et al., 2012; Kirsten et al., 2012; Malkova et al., 2012) led
to increased stereotypies and locomotion. However, additional
deficits in motor coordination, learning/memory and social
interaction, and the presence of immune deposits in the brain
severely hamper their face validity for TS (Yaddanapudi et al.,
2010).
Transplantation into naïve animals of antibodies derived from
animals actively immunized with patients’ sera (Taylor et al.,
2002; Singer et al., 2005; Martin et al., 2008; Zhang et al., 2012) led
to a similar phenotype and episodic vocalizations were reported
(Hallett et al., 2000).
The importance of stress as a factor able to exacerbate tics has
for long been referred by patients. Stress paradigms have proven
capable of worsening the phenotype in animal models and have
been recently introduced as a way to improve their validity (Xu
et al., 2015a,b).
Stress paradigms can also be used to evaluate the ability
of different stressors to predispose to abnormal behavioral
development (Hall, 1998; Pryce and Feldon, 2003). For istance,
maternal deprivation affects the social, emotional and attention
domain of primates leading often to stereotypies or other
dysfunctional motor activities (Márquez-Arias et al., 2010;
Rommeck et al., 2011; Table 4).
Related Psychiatric Conditions
ADHD
Attention-deficit/hyperactivity disorder (ADHD) is the most
common comorbidity in TS.
ADHD is a neurodevelopmental disorder with an onset before
age 12 (DSM-5). It affects about 5% of children, with 2–4:1
boys/girls prevalence (Polanczyk and Rohde, 2007). The three
core symptoms of ADHD are inattention, motor hyperactivity,
and increased impulsivity. Inattention refers to disorganization
and difficulty in sustaining focus; hyperactivity manifests as
excessive motor activity or talking activeness in inappropriate
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situations; impulsivity refers to the tendency to perform, without
adequate forethought.
The cause of ADHD still remains elusive but it most likely
results from a combination of cofactors that can be genetic,
developmental, and/or environmental. The observation that the
most effective drugs for ADHD treatment are psychostimulants
(Sagvolden et al., 2005), implicates a role for catecholamines
in the development of the disease. Indeed, the dopaminergic
D1, D4, and D5 receptor genes, the α2-adrenoceptor gene, and
both dopamine and norepinephrine transporters (DAT1, NET1)
genes show polymorphisms in ADHD patients (Cook et al., 1995;
Manor et al., 2004; Bobb et al., 2005; Park et al., 2005; Kickler
et al., 2009). Serotonin has also been indicated to play a role in
ADHD, as suggested by polymorphisms in genes that encode the
serotonin transporter and the serotonin 1B receptor (Kent et al.,
2002).
Since ADHD affects 60–80% of children with TS (Khalifa
and Knorring, 2007), a common pathophysiological link between
these two disorders seems evident. A debate is going on whether
the two pathologies are independent (additive model), combined
(interactive model), or a phenotype subgroup of one of the two
major clinical forms (phenotype model) (Cavanna et al., 2009;
Greimel et al., 2011; Schlander et al., 2011), however, there is
increasing evidence for an additive model (Lebowitz et al., 2012;
Roessner et al., 2007).
Modeling ADHD
Inattention, motor hyperactivity, and increased impulsivity are
the three core features of ADHD. They have been differently
modeled using (i) genetic manipulation, for instance in DAT-KO
mice, coloboma mutant mice, nicotinic receptor mutant mice,
human thyroid receptor expressing mice, GAT1-KO mice, ACC
mice, andmutant tachinin-1mice (Gainetdinov andCaron, 2000;
Granon and Changeux, 2006; Siesser et al., 2006; Bruno et al.,
2007; Yan et al., 2009; Zimmermann et al., 2014), (ii) selective
breeding, as in SHR rats and Naples high excitability rats (Sadile
et al., 1993; Sagvolden, 2000) (iii) insulting events during early
developmental stages through 6-hydroxydopamine lesion and
prenatal nicotine exposure (Stead et al., 2006; Schneider et al.,
2011; Zhu et al., 2012; Freund et al., 2014) (iv) social isolation
(Ouchi et al., 2013).
To validate these models, sustained attention deficits should
be shown when stimuli are widely spaced in time, hyperactivity
should be absent in novel situations and develop gradually over
time and impulsivity should be sensitive to reinforcers (for review
see Sagvolden et al., 2005).
SHR rats have been themost extensively usedmodel of ADHD
and feature all core aspects of this disorders. However, in SHR
rats and in all previously listed ADHD models tic-like behaviors
have not been documented.
Animal models of TS showing comorbid full ADHD spectrum
have not been reported so far, but some validity for the
single features were documented: hyperactivity was associated
to specific bicuculline injections sites in the dorsal striatum
and dorsal GPe of primates (Grabli et al., 2004; Worbe et al.,
2009) and attention deficit occurred after injections in associative
regions of the GPe (Grabli et al., 2004).
OCD
OCD is a neuropsychiatric disease that is frequently found as
comorbidity in adult TS patients. It is a chronic disorder, which
affects approximately 1–3% of the population (Pallanti et al.,
2011).
According to DSM-5, obsessions, compulsions, or both, have
to be present for an OCD diagnosis. Obsessions are defined as
recurrent and persistent thoughts (e.g., fear of contamination),
urges (e.g., need to wash hands), or images (e.g., of a violent or
horrific scene) that are experienced as intrusive and unwanted,
and cause marked anxiety and distress. The individual will
try to suppress or to neutralize obsessions with some other
thoughts or actions, for instance by performing a compulsion.
Compulsions are defined as repetitive mental acts (e.g., counting)
or behaviors (e.g., washing hands) performed in response to an
obsession or according to rules that must be applied rigidly to
a clearly excessive point when they become disruptive for daily
living. OCD patients are able to recognize their obsessions and
compulsions, but are unable to avoid them (Koran et al., 1996;
Okasha et al., 2000).
The etiology of OCD is not completely understood.
Serotonin was the first neurotransmitter to be associated
with OCD pathophysiology when selective serotonin re-uptake
inhibitors (SSRIs) were shown to be efficacious in treating OCD
(Barr et al., 1992). However, many patients do not respond to
SSRIs treatment suggesting the additional involvement of other
NTs such as dopamine (Carey et al., 2005; Taj et al., 2013), GABA
(Simpson et al., 2012; Russo and Pietsch, 2013; Russo et al., 2014)
and particularly glutamate (Arnold et al., 2006; Alonso et al.,
2012; Porton et al., 2013). Growing evidence indicates the latter as
a putative central player in OCD pathophysiology, strengthening
the glutamate hypothesis of OCD and opening a new window for
the development of novel treatment strategies (Coric et al., 2005;
Grant et al., 2007; Bakhla et al., 2013).
Dopamine, GABA, and glutamate are commonly associated
to CSTC circuit malfunction, implicating a role for this circuit
in OCD pathophysiology (Stahl, 1988; Insel and Winslow, 1992;
Graybiel and Rauch, 2000; Welch et al., 2007). Such alterations
are also thought to be causative of tics, which 30% of OCD
patients develop (Bloch et al., 2006; Pallanti et al., 2011). Tics and
compulsions are now considered to be two different sides of the
same coin that may be grouped under the general term of “tic-
like” activities (Lombroso and Scahill, 2008; Worbe et al., 2010;
Cath et al., 2011; Martino et al., 2013).
Modeling OCD
In animal models reported to have validity for OCD the presence
of obsessions has been reasonably left aside and the focus
was on the presence of behavioral compulsivity, intended as
the performance of repetitive, and perseverating actions and
stereotypies (for review see Alonso et al., 2015).
It is interesting to underline the existence of an analog to OCD
in dogs: the Canine Compulsive Disorder (CCD), which leads to
excessive tail chasing, light/shadow chasing, and flank sucking.
These behaviors are attenuated with the same treatments used for
OCD, indicating that its study may help elucidate the etiology of
compulsive disorders (Ogata et al., 2013).
Frontiers in Neuroscience | www.frontiersin.org 10 April 2016 | Volume 10 | Article 133
Nespoli et al. Animal Models of Tourette Syndrome
Numerous validated approaches have been developed aiming
to evaluate and quantify compulsive-like behaviors. Examples are
the schedule-induced polydipsia (Woods et al., 1993), the marble
burying test (Ichimaru et al., 1995), the signal attenuation test
(Joel et al., 2005) the nest building test (Hoffman and Rueda
Morales, 2012) and the nestlet shredding test (Angoa-Pérez et al.,
2012). These models provide the greatest ease of use and do not
require any pharmacological or genetic intervention but on the
other hand they do not offer any pathophysiological information.
Based on the clinical evidence for an involvement of
serotonin in OCD, OCD-like behaviors are induced in animals
by treatments with serotonergic agonists 8-hydroxy-2-(di-n-
propylamino) tetralin (8-OH-DPAT) (Carli et al., 2006; Arora
et al., 2013) andm-chlorophenylpiperazine (mCPP) (Kreiss et al.,
2013), as well as with the serotonin releasing agent compound
48–80 (Wald et al., 2009). Mice lacking TPH2, the rate-limiting
enzyme of serotonin synthesis in the brain, display highly
repetitive and compulsive behaviors (Kane et al., 2012).
The glutamatergic hypothesis of OCD finds also a strong
support in animal models. In mice lacking the AMPA receptor
trafficking protein SAPAP3, glutamate signaling dysfunction is
accompanied by compulsive grooming behavior (Welch et al.,
2007; Wu et al., 2012).
Astrocyte-specific glutamate transporter (GLT1) inducible
knockout mice exhibit OCD/TS-like behavioral spectrum, with
marked increased self-injurious grooming behavior (Aida et al.,
2015). Interestigly, this is the first hint of a role for non-neuronal
cells in this brain disorder. Lastly, transmembrane protein Slitrk5
KO mice show OCD-like behavioral abnormalities that seem
to be associated to a deficient corticostriatal neurotransmission
(Abelson et al., 2005; Shmelkov et al., 2010). Slitrk5 belongs to
the same family of Slitrk1, a protein associated to TS.
Dopamine, that has been largely associated to TS and ADHD,
is supported by animal models findings to play a role in
compulsive behaviors. The treatment with the DR2 agonist
quinpirole in mice marks the expression of the behavioral
repertoire and long-term exposure to this drug leads to
hyperactivity in A/J mice (De Haas et al., 2012). In rats,
chronic administration of the same compound causes compulsive
checking (Szechtman et al., 1998; Alkhatib et al., 2013).
In the D1CT-7 transgenic mouse, the modulation of the
glutamatergic cortical output on the striatal circuits obtained
through the chronic potentiation of cortical and limbic D1-
expressing neurons leads to the development not only of
compulsive behaviors, but also of tics. This makes it the only
model of comorbid tics and OCD proposed so far (Smicun et al.,
1999; Nordstrom and Burton, 2002).
CONCLUSIONS
Animal models are gaining an important role in understanding
TS pathophysiology and in investigating new treatment options.
In the recent years numerous models have been developed, many
of which summarize more than a single aspect of the syndrome.
Through animal models the idea of a major role for the
striatum in tics generation, already suggested by imaging and
post mortem studies, was importantly strengthened. In fact,
independent approaches used to model TS succeeded in showing
increased grooming and tic-like phenotype following striatal
structural and functional alterations. This indicates the striatum
as a research target worth investing more efforts.
Reproducing tics, the core feature of TS, is the actual greatest
challenge for animal models. A TS diagnosis requires the
coexistence of multiple motor and at least a vocal tic, but so far
researchers focused on motor tics while the presence and cause
of vocal tics has been poorly investigated and require further
attention.
The difference between tics and other movement disorders
can be detected in humans but it is subtler in animals that
physiologically account a wide range of species-specific repetitive
movements in their repertoire. In patients, tics have the peculiar
features of being preceded by a PU, have a waxing and waning
pattern and can be voluntarily repressed. These distinctive
features of tics are difficult to observe in animals and result
severely biased by the approach used. Stereotypies, which are
fixed, prolonged, and rhythmic repetitive behaviors with an early
onset and a fixed presentation pattern (DSM-5), can be confused
with tics in animal models, though they are separated clinical
entities. A discriminative method between these two motor
phenotypes in animal models could increase face validity and
help the development of more targeted therapeutic strategies.
To achieve this point, a better understanding of the animals’
behavioral spectrum along with a beter knowledge of tics’
generating mechanisms are needed.
Finally, TS is classified as a neurodevelopmental syndrome,
as it is typically diagnosed in childhood or adolescence, and tics
show spontaneous and substantial reduction toward the end of
the second decade of life in more than half of patients. However,
so far, animal model research lacked the investigation of the
way development affects the phenotype. Juvenile animal models
could elucidate the impact of developmental mechanisms and
importantly help the study of more effective and safer therapies
for young patients.
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